Tanzer D J, Smith R E
Cornea Service, Doheny Eye Institute, University of Southern California, Los Angeles, USA.
Cornea. 1999 Nov;18(6):729-30. doi: 10.1097/00003226-199911000-00017.
To report the extended clinical course of a case of superficial punctate keratitis of Thygeson.
A 59-year-old woman with a 40-year history of superficial punctate keratitis of Thygeson is presented, providing a forum to discuss the chronicity of the disease, its treatment, and the potential complications.
Our patient has been treated over the years with mild topical corticosteroids, usually with favorable results. Given the chronicity of superficial punctate keratitis of Thygeson, long-term treatment with topical corticosteroids carries the possible side effects of iatrogenic cataract formation and steroid-induced glaucoma, neither of which was seen in our patient.
Superficial punctate keratitis of Thygeson is usually a benign, self-limited disease with exacerbations and remissions. Ophthalmologists must exercise care when using long-term corticosteroid treatment in this condition.
报告1例蒂格森表浅点状角膜炎的长期临床病程。
介绍1例有40年蒂格森表浅点状角膜炎病史的59岁女性患者，提供一个讨论该疾病的慢性病程、治疗方法及潜在并发症的平台。
多年来我们的患者一直使用轻度局部皮质类固醇进行治疗，通常效果良好。鉴于蒂格森表浅点状角膜炎的慢性病程，长期使用局部皮质类固醇治疗可能会有医源性白内障形成和类固醇性青光眼等副作用，但我们的患者均未出现这些情况。
蒂格森表浅点状角膜炎通常是一种良性的、自限性疾病，有病情加重和缓解期。眼科医生在这种情况下使用长期皮质类固醇治疗时必须谨慎。
